ArticleClinical and experimental medicine2023

Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responses.

Simon Heller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.